Sun Pharmaceutical Industries is a manufacturer of peptides based in India (Mumbai). Direct manufacturer. Founded 1983. Key products include peptide APIs, generic APIs.
Listing reviewed October 2026.
Mumbai-based maker of generic and specialty medicines and their APIs, which describes itself as India's No. 1 pharmaceutical company. Holds active US Drug Master Files for semaglutide and liraglutide API.
Directory assessment: Sun Pharmaceutical Industries is listed as a manufacturer in the peptide supply chain, serving Asia markets from India (Mumbai). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 2 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.
DMF numbers from the FDA quarterly DMF list. A filed DMF is not FDA approval; its contents are confidential. Reviewed 2026-10-15.